- Report
- January 2026
- 211 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- January 2026
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- November 2025
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- November 2025
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- November 2025
- 191 Pages
Global
From €4446EUR$4,950USD£3,798GBP
- Report
- November 2025
- 109 Pages
Global
From €3099EUR$3,450USD£2,647GBP
- Report
- September 2025
- 85 Pages
United States
From €3144EUR$3,500USD£2,685GBP
- Report
- October 2025
- 135 Pages
United States
From €2290EUR$2,550USD£1,956GBP
- Report
- October 2025
- 110 Pages
North America
From €2919EUR$3,250USD£2,493GBP
- Report
- November 2025
- 70 Pages
Middle East, Africa
From €3099EUR$3,450USD£2,647GBP
- Report
- November 2025
- 97 Pages
Asia Pacific
From €3548EUR$3,950USD£3,031GBP
- Report
- November 2025
- 100 Pages
Europe
From €3548EUR$3,950USD£3,031GBP
- Report
- November 2025
- 101 Pages
North America
From €3099EUR$3,450USD£2,647GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4042EUR$4,500USD£3,453GBP
- Report
- October 2025
- 82 Pages
Middle East
From €4042EUR$4,500USD£3,453GBP
- Report
- October 2024
- 141 Pages
Global
From €2686EUR$2,990USD£2,294GBP
- Report
- January 2022
- 249 Pages
Global
From €3368EUR$3,750USD£2,877GBP
- Report
- December 2024
- 58 Pages
Europe
From €2919EUR$3,250USD£2,493GBP
- Report
- June 2024
- 371 Pages
Global
From €4446EUR$4,950USD£3,798GBP

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development.
Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more